PHREND®—A Real-World Data-Driven Tool Supporting Clinical Decisions to Optimize Treatment in Relapsing-Remitting Multiple Sclerosis

BackgroundWith increasing availability of disease-modifying therapies (DMTs), treatment decisions in relapsing-remitting multiple sclerosis (RRMS) have become complex. Data-driven algorithms based on real-world outcomes may help clinicians optimize control of disease activity in routine praxis.Objec...

Ful tanımlama

Kaydedildi:

Detaylı Bibliyografya
Asıl Yazarlar:	Stefan Braune, Elisabeth Stuehler, Yanic Heer, Philip van Hoevell, Arnfin Bergmann, NeuroTransData Study Group
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	Frontiers Media S.A. 2022-03-01
Seri Bilgileri:	Frontiers in Digital Health
Konular:	multiple sclerosis (MS) personalized medicine disease modifying agent real word data treatment effectiveness
Online Erişim:	https://www.frontiersin.org/articles/10.3389/fdgth.2022.856829/full
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

PHREND®—A Real-World Data-Driven Tool Supporting Clinical Decisions to Optimize Treatment in Relapsing-Remitting Multiple Sclerosis

Benzer Materyaller